Cision PR Newswire

Accident Accident Air Pollution All News Annoucement Argriculture Art ASEAN Book

Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma

SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business segments. With the gradual realization of commercial launch and international expansion for its core products, the company is accelerating its transition from Biotech to Biopharma: CEVIRA®, the world's first...

Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering

Cision PR Newswire

Why Helsinki Should Be on Every Art Lover’s Travel List in Summer 2027

HELSINKI, Aug. 28, 2026 /PRNewswire/ -- Following a record-breaking edition that attracted more than half...

Cision PR Newswire

Lasfit Expands Its Vehicle-Specific Ford F-150 Upgrade Solutions Across Lighting, Protection and Outdoor Use

LOS ANGELES, Aug. 28, 2026 /PRNewswire/ -- Lasfit has rolled out brand-new LED ditch...

Cision PR Newswire

InxMed Announces Publication in The Lancet Oncology Featuring Encouraging Antitumor Activity of Ifebemtinib in Combination with Garsorasib in Previously Treated Metastatic Colorectal Cancer (CRC)...

NANJING, China, Aug. 28, 2026 /PRNewswire/ -- InxMed Co., Ltd ("InxMed"), a clinical-stage biotechnology...

Cision PR Newswire

Triller Joins Forces with Baron Davis’ BIG and Influencer Platform REACH for NBA All-Star Weekend

The...

Tuya to Report Fourth Quarter 2024 Financial Results on February 26, 2025 Eastern Time

SANTA CLARA, Calif., Feb. 14, 2025 /PRNewswire/ -- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391), a global leading cloud platform service...

Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases

BOSTON,...

Cision PR Newswire

Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma

Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering

Why Helsinki Should Be on Every Art Lover’s Travel List in Summer 2027

Lasfit Expands Its Vehicle-Specific Ford F-150 Upgrade Solutions Across Lighting, Protection and Outdoor Use

InxMed Announces Publication in The Lancet Oncology Featuring Encouraging Antitumor Activity of Ifebemtinib in Combination with Garsorasib in Previously Treated Metastatic Colorectal Cancer (CRC)...

ABOUT US

FOLLOW US